Trials / Conditions / Acute Myeloid Leukemias
Acute Myeloid Leukemias
4 registered clinical trials studyying Acute Myeloid Leukemias — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) NCT07211958 | Syndax Pharmaceuticals | Phase 3 |
| Recruiting | A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) NCT06950034 | Solu Therapeutics, Inc | Phase 1 |
| Recruiting | A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias NCT06226571 | Syndax Pharmaceuticals | Phase 1 |
| Unknown | Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells NCT01220544 | Charite University, Berlin, Germany | Phase 1 / Phase 2 |